Title | Treatment of Acute Leukemias [electronic resource] : New Directions for Clinical Research / edited by Ching-Hon Pui |
---|---|
Imprint | Totowa, NJ : Humana Press : Imprint: Humana Press, 2003 |
Connect to | http://dx.doi.org/10.1007/978-1-59259-307-1 |
Descript | XVI, 562 p. online resource |
I: Diagnosis, Classification, and Prognosis -- 1 Classification of Acute Leukemias: Perspective 1 -- 2 Classification of Acute Leukemias: Perspective 2 -- II: Chemotherapeutic Strategies -- 3 Biology and Treatment of Infant Leukemias: Perspective 1 -- 4 Biology and Treatment of Acute Leukemias in Infants: Perspective 2 -- 5 Treatment of Childhood Acute Lymphoblastic Leukemia -- 6 Treatment of Childhood Acute Lymphoblastic Leukemia: The Dana-Farber Cancer Institute ALL Consortium Perspective -- 7 Treatment of Acute Lymphoblastic Leukemia in Adolescents and Young Adults: Lessons Learned and Future Directions -- 8 Treatment of Adolescents and Young Adults with Acute Lymphoblastic Leukemia: Childrenโs Cancer Group Trials -- 9 Treatment of Adult Acute Lymphoblastic Leukemia: Perspective 1 -- 10 Treatment of Adult Acute Lymphoblastic Leukemia: Perspective 2 -- 11 Central Nervous SystemโDirected Therapy for Acute Lymphoblastic Leukemia -- 12 Diagnosis, Prophylaxis, and Treatment of Central Nervous System Involvement in Acute Lymphoblastic Leukemia -- 13 Treatment of Relapsed Acute Lymphoblastic Leukemia: Perspective 1 -- 14 Treatment of Relapsed Acute Lymphoblastic Leukemia: Perspective 2 -- 15 Treatment of B-Cell Acute Lymphoblastic Leukemia: Perspective 1 -- 16 Treatment of B-Cell Acute Lymphoblastic Leukemia: Perspective 2 -- 17 Treatment of Acute Myeloid Leukemia in Children -- 18 Treatment of Childhood Acute Myeloid Leukemia -- I. Acute Myeloid Leukemia in Adults -- 19 Therapy of Acute Myeloid Leukemia in Adults -- 20 Treatment of Adult Acute Myelogenous Leukemia -- J. Acute Promyelocytic Leukemia -- 21 Acute Promyelocytic Leukemia: Perspective 1 -- 22 Acute Promyelocytic Leukemia: Perspective 2 -- K. Childhood Leukemias in Underprivileged Countries -- 23 Treatment of Childhood Leukemias in Underprivileged Countries -- 24 How to Confront the Problem of Treatment of Childhood Leukemias in Underprivileged Populations -- III: Antileukemic Drugs -- 25 Rationale for High-Dose Methotrexate in Childhood Acute Lymphoblastic Leukemia -- 26 Role of Methotrexate in the Treatment of Acute Lymphoblastic Leukemia -- 27 Asparaginase -- 28 Asparaginase Treatment -- 29 Antipurines in Childhood Acute Lymphoblastic Leukemia -- 30 Antipurines -- 31 Etoposide in Acute Leukemias: Therapeutic and Pharmacokinetic Considerations -- 32 Etoposide and Teniposide: Clinical Applications with a Focus on Leukemia -- IV: Hematopoietic Stem Cell Transplantation -- 33 Hematopoietic Stem Cell Transplantation: Perspective 1 -- 34 Hematopoietic Stem Cell Transplantation: Perspective 2 -- V: Biologic Treatments -- 35 Hematopoietic Growth Factors in Patients with Acute Leukemia -- 36 Hematopoietic Growth Factor Treatment in Leukemia -- 37 Immunotherapy of Leukemia -- 38 Therapy of Acute Leukemia with Monoclonal Antibodies and Immunoconjugates -- VI: Drug Resistance -- 39 Drug Resistance in Acute Leukemias -- 40 Drug Resistance in Acute Leukemia -- VII: Minimal Residual Disease -- 41 Minimal Residual Disease -- 42 Molecular Monitoring of Minimal Residual Disease